SCHEMBL25975953

SCHEMBL25975953

CC(O)NCCCCCC(=O)NCC(=O)NCC(=O)NC(C)Cc1ccccc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SIGMAR1 Q99720 6/20 0.46
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.43
ALDH1A1 P00352 1/20 0.43
MMP2 P08253 1/20 0.43
LMNA P02545 2/20 0.43
PKM P14618 1/20 0.43
NPSR1 Q6W5P4 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25976421 0.85 PSMB5 (0.49) HDAC3HDAC4HDAC1HDAC7HDAC2
SCHEMBL25668395 0.83 FAAH (0.44) NPC1RAB9AKMT2AMEN1MMP2
SCHEMBL25976092 0.82 NPC1 (0.42) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL24982400 0.79 SMN1; SMN2 (0.47) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL25975656 0.79 NPC1 (0.51) NPC1RAB9ASIGMAR1KMT2AMEN1
SCHEMBL24183747 0.78 SMN1; SMN2 (0.64) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL24642659 0.78 NPC1 (0.59) NPC1RAB9ASIGMAR1KMT2AMEN1
SCHEMBL10136058 0.76 NPC1 (0.58) NPC1RAB9AKMT2AMEN1ALDH1A1
SCHEMBL19293154 0.76 NPC1 (0.58) NPC1RAB9ASIGMAR1KMT2AMEN1
SCHEMBL27710873 0.76 NPC1 (0.58) NPC1RAB9AKMT2AMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4223318-A1 ANTITUMOR COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Duality Biologics (Suzhou) Co., Ltd. (CN) 2023-08-09 EP disclosed